RCKTLawsuits•businesswire•
RCKT INVESTOR ALERT: Robbins Geller Rudman & Dowd Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Sentiment:Negative (-80)
Summary
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: Rocket Pharm business & prospects, resulting in its stock trading at inflated prices.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 14, 2025 by businesswire